Skip to main content

Acinetobacter Baumannii-calcoaceticus Complex clinical trials at UC Davis
1 research study open to eligible people

  • Study of Experimental Sulbactam-ETX2514 Infections Caused by Acinetobacter baumannii-calcoaceticus Complex

    open to eligible people ages 18 years and up

    This is a 2-part study, with Part A being the randomized, controlled portion of the study in patients with ABC (Acinetobacter baumannii-calcoaceticus Complex) hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or bacteremia. Part B is the single-group portion of the study and includes ABC infections that are resistant to or have failed colistin treatment.

    Sacramento, California and other locations

Last updated: